Inactive Instrument

InterMune Inc Stock

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

14-09-16	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
14-09-04	Roche : rules out mega deals, open to smaller ones - paper	RE

14-09-16	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
14-09-04	Roche : rules out mega deals, open to smaller ones - paper	RE
14-08-27	Biogen Idec : InterMune drug may offer big upside to Roche if aimed at liver	RE
14-08-25	Burger King Worldwide : S&P 500 sets record high but fails to hold 2,000 mark	RE
14-08-25	CHUGAI PHARMACEUTICAL : Roche to buy U.S. biotech firm InterMune for $8.3 billion	RE
14-03-19	Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	RE
13-06-06	NVIDIA Corporation : SAC insider-trading probe could last years	RE
13-03-20	Weight Watchers International, Inc. : SAC Capital up 4 percent this year as probe continues	RE
13-03-15	Morgan Stanley : Cohen's SAC to pay $616 million in SEC insider trade settlement	RE
12-12-28	InterMune, Inc. : Blackstone seen sticking with SAC despite insider trading probe	RE
12-12-19	Weight Watchers International, Inc. : SAC Capital's top consumer trader draws U.S. scrutiny	RE
12-12-07	Elan Corporation, plc : Exclusive: U.S. authorities probe SAC for Weight Watchers - sources	RE
12-07-23	InterMune, Inc. : InterMune posts lower-than-expected revenue	RE

14-10-02	InterMune : Announces Effective Date of Make Whole Fundamental Change and Offer to Purchase to Holders of 2.50% Senior Convertible Notes Due 2018	PU
14-09-19	InterMune : Reports Memorandum of Understanding in Connection with Consolidated Delaware Action	PR
14-09-05	InterMune : Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015	PR
14-08-27	InterMune : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
14-08-27	INTERMUNE : SHAREHOLDER ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG	BU

14-09-04	Roche : exclut une mega-fusion, ouvert à de plus petits rachats
14-08-25	Wall Street finit dans le vert, le S&P passe un cap
14-08-25	Burger King Worldwide : Wall Street ouvre en hausse sur un nouveau record du S&P
14-08-25	Wall Street ouvre en hausse avec les M&A et l'Europe
14-08-25	Apple : USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Edward Harrington CEO	Chief Executive Officer	-	-
Marianne T. Armstrong CTO	Chief Tech/Sci/R&D Officer	71	2002-03-31
Carla Fiankan LAW	General Counsel	-	2011-07-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+0.20%	+1.73%	-13.36%	-11.02%	43.68B
REVOLUTION MEDICINES, INC.	-3.58%	-7.56%	+243.47%	+464.57%	30.65B
IQVIA HOLDINGS INC.	-2.19%	+0.07%	+14.02%	-11.82%	30.4B
BEONE MEDICINES AG	-1.70%	-5.52%	+0.07%	+22.02%	29.31B
CELLTRION, INC.	-1.59%	-6.51%	+8.30%	+13.51%	24.2B
MEDPACE HOLDINGS, INC.	-0.23%	+3.31%	+52.25%	+124.06%	13.3B
ASCENDIS PHARMA A/S	-1.61%	-3.23%	-	-	13.03B
EUROFINS SCIENTIFIC SE	+0.70%	+1.29%	+10.50%	+10.61%	13.21B
IONIS PHARMACEUTICALS, INC.	-1.69%	-0.68%	+99.02%	+80.37%	12.12B
Average	-1.30%	-1.21%	+51.78%	+86.54%	23.32B
Weighted average by Cap.	-1.39%	-1.69%	+48.47%	+87.05%